| Mon, Dec 21, 2009 | | • | VALEANT PHARMACEUTICALS INTERNATIONAL Files SEC form 8-K, Entry into a Material Definitive Agreement, Change in Direc
EDGAR Online (Mon, Dec 21)
| | Thu, Dec 10, 2009 | | • | [$$] Keeping an Eye on Drug Pipelines
at The Wall Street Journal Online (Thu, Dec 10)
| | Mon, Dec 7, 2009 | | • | Valeant buying lab in Quebec
at bizjournals.com (Mon, Dec 7)
| | • | Valeant to Acquire Laboratoire Dr. Renaud in Canada
PR Newswire (Mon, Dec 7)
| | Tue, Dec 1, 2009 | | • | VALEANT PHARMACEUTICALS INTERNATIONAL Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online (Tue, Dec 1)
| | Mon, Nov 23, 2009 | | • | Valeant Pharma begins selling generic IBS drug
AP (Mon, Nov 23)
| | • | [$$] Valeant Shares Fall Ill
at Barrons.com (Mon, Nov 23)
| | • | Barron's Magazine First Read: Dividends, VRX, DISCA
at Barrons.com (Mon, Nov 23)
| | • | Oceanside Pharmaceuticals Announces Launch of Librax(R) AG
PR Newswire (Mon, Nov 23)
| | Sat, Nov 21, 2009 | | • | This Weekend's Barron's: Dividend Paying Stocks; BB&T Is the Banking Belle of the South; Is There Any Hope for Atlantic City
at Barrons.com (Sat, Nov 21)
| | • | [$$] Hot Drug Stock in Need of a Chill Pill
at Barrons.com (Sat, Nov 21)
| | Wed, Nov 18, 2009 | | • | Drugmaker Reinvents Itself And Expands Footprint Internationally
Investor's Business Daily (Wed, Nov 18)
| | Wed, Nov 11, 2009 | | • | Big Value in Valeant
RealMoney by TheStreet.com (Wed, Nov 11)
| | Tue, Nov 10, 2009 | | • | VALEANT PHARMACEUTICALS INTERNATIONAL Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal
EDGAR Online (Tue, Nov 10)
| | • | UBS Research Equity Analyst Picks Top Stocks In Large Cap Biotech Sector
Wall Street Transcript (Tue, Nov 10)
| | Fri, Nov 6, 2009 | | • | VALEANT PHARMACEUTICALS INTERNATIONAL Financials
EDGAR Online Financials (Fri, Nov 6)
| | Tue, Nov 3, 2009 | | • | Valeant Pharmaceuticals Highlights Taribavirin Phase IIb End of Study Data Presentation at American Association for the Study of Liver Disease (AASLD) Annual Meeting
PR Newswire (Tue, Nov 3)
| | Mon, Nov 2, 2009 | | • | Valeant Pharmaceuticals International Q3 2009 Earnings Call Transcript
at Seeking Alpha (Mon, Nov 2)
| | • | Valeant: It Turns Out that Wrinkles Are Worth Quite a Lot
at Seeking Alpha (Mon, Nov 2)
| | • | Valeant 3Q net income down, results top forecast
AP (Mon, Nov 2)
|
Add VRX News to My Yahoo!:
 
| |
|
0.51% Nasdaq 
Headlines
